Percutaneous Heart Valve Therapy - Options, Risks and Benefits

Login or register to view PDF.
Login or register to view eJournal.
Abstract

Transcatheter valve therapy is emerging as an effective option for aortic valve stenosis and mitral regurgitation. In 1992, Anderson demonstrated the feasibility of percutaneous implantation of catheter-based valve prosthesis. Since then, many technical and device advances have been made, and transcatheter aortic valve implantation and mitral valve repair have became a concrete alternative to surgical replacement.

Disclosure
Gian Paolo Ussia is proctor physician for CoreValve®. The remaining authors have no conflicts of interest to declare.
Correspondence
Corrado Tamburino, Director of Cardiology Division, Post-graduate School of Cardiology, Ferrarotto Hospital, University of Catania, Italy. E: tambucor@unict.it
Received date
11 August 2009
Accepted date
30 October 2010
Citation
European Cardiology - Volume 6 Issue 1;2010:6(1):65-74
Correspondence
Corrado Tamburino, Director of Cardiology Division, Post-graduate School of Cardiology, Ferrarotto Hospital, University of Catania, Italy. E: tambucor@unict.it
PREMIUM CONTENTArticles are free-to-download for registered users only. It's free to register and takes less than 1 minute. Please either Login or register to read in HTML & eJournal format or to download our PDFs. *Your details will only be used internally to learn more about our audience and will never be passed on.

Vegan Heart – The Blog of Heather Shenkman MD, FACC

  • 19 November 2014
    I had an awesome triathlon season -- three Ironman 70.3 events, moving from top 27%, to top 23%, to top 20% in my age group.After my nearly ten years...
  • 28 October 2014
    Last week, I attended the annual meeting of the American College of Lifestyle Medicine.  Not only was it an opportunity to hear some of my...

Partners